EPO official on quality concerns; EU-China anti-suit injunction dispute escalates; new 5G Multimode patent pool; Qualcomm, Huawei and InterDigital execs discuss FRAND; US patent bills roundup; plus much more
Everything we covered on IAM over the last seven days – and all you need to know from the global IP market to set yourself up for the start of another busy week
The Long Read
Senator Patrick Leahy's work has dominated the US patent policy landscape and will continue to shape debate for years to come. As he steps down from public life, IAM looks at his legacy. Read more here
MONDAY 12 December
Speaking to IAM, the EPO’s VP for Patent Granting Process says efficiency-over-quality criticisms are unfounded. Read more here
Docket Navigator data shows the US District Court for the District of New Jersey was a key battleground for biotechnology and organic chemistry patent disputes. Read more here
TUESDAY 13 December
The European Commissions has escalated its WTO anti-suit injunction dispute with China. Read more here
Two major issues often arise in patent licence agreements, so each side must carefully craft provisions covering affiliates and granting termination rights. Read more here
A Qualcomm executive and Invent Together’s director discuss the size of the missed opportunity arising from under representation in inventors at a New York event. Read more here
WEDNESDAY 14 December
Sisvel announced the launch of a 5G Multimode patent pool. Read more here
Adeia – the IP licensing business that spun out from Xperi this Autumn – has announced a string of media licence renewals which mark a strong start, but investors scrutinise revenue fluctuations. Read more here
THURSDAY 15 December
Following a relatively barren year for pharma dealmaking, Amgen announced an agreement to pay $28.3 billion to buy Horizon Therapeutics. Read more here
IAM counts down the top five of the US patent world’s biggest news nuggets of 2022. Read more here
FRIDAY 16 December
IP licensing leaders from Qualcomm, Huawei and InterDigital had a spirited discussion on FRAND licensing at component level at an IAM event. Watch the full debate here
IAM published its annual Strategy 300 Global Leaders and asked six practitioners about how innovators are stepping up to battle the climate crisis. Read more here
US patent bills are prominent but facing prospects mixed as US Congress winds down. Read more here
Intellectual Property Owners Association backs US study on covid therapeutics prior to TRIPS waiver extension. Read more here
SATURDAY 17 December
Bird & Bird Partner Richard Vary weighs-in on the FRAND debate, arguing the case for SEP owners. Read more here
